{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:28Z","timestamp":1791225988858,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijpharm.2012.08.024","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T04:01:01Z","timestamp":1345694461000},"page":"213-220","source":"Crossref","is-referenced-by-count":91,"title":["In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles"],"prefix":"10.1016","volume":"437","author":[{"given":"Nathalie","family":"Reix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Parat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Seyfritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remmelt","family":"Van Der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Epure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Danicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Jeandidier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Pinget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Fr\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Sigrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.08.024_bib0005","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/193229680900300322","article-title":"Oral insulin: the rational for this approach and current developments","volume":"3","author":"Arbit","year":"2009","journal-title":"J. Diab. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0928-0987(03)00146-5","article-title":"Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?","volume":"19","author":"Behrens","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0015","unstructured":"Belcourt, A., Danicher, L., Fr\u00e8re, Y., 2004. Vector for oral administration. Patent WO2004096172."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejpb.2011.10.021","article-title":"Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles","volume":"80","author":"Benfer","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/17425240903579971","article-title":"Designer nanoparticles: Incorporating size, shape, and triggered release into nanoscale drug carriers","volume":"7","author":"Caldorera-Moore","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0030","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.biomaterials.2009.01.057","article-title":"The uptake and intracellular fate of PLGA NPs in epithelial cells","volume":"30","author":"Cartiera","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2008.09.073","article-title":"A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA NPs","volume":"133","author":"Cohen-Sela","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA\u2013Hp55 NPs for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0045","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1021\/js970124i","article-title":"Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin","volume":"86","author":"Damg\u00e9","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0050","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1023\/A:1012126301290","article-title":"The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent","volume":"14","author":"Desai","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2006.09.018","article-title":"In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles","volume":"331","author":"Dong","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0060","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/jps.21544","article-title":"A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study","volume":"98","author":"Emami","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0065","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI119271","article-title":"Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model","volume":"99","author":"Fasano","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","article-title":"The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems \u2013 a review","volume":"415","author":"Fredenberg","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0075","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","article-title":"A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats","volume":"5","author":"Garcion","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2009.10.008","article-title":"Interaction of biodegradable NPs with intestinal cells: the effect of surface hydrophilicity","volume":"390","author":"Gaumet","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/279679a0","article-title":"Coated pits, coated vesicles, and receptor-mediated endocytosis","volume":"279","author":"Goldstein","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0090","doi-asserted-by":"crossref","first-page":"E100","DOI":"10.1208\/pt060116","article-title":"Eudragit S100 entrapped insulin microspheres for oral delivery","volume":"6","author":"Jain","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0095","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2007.02.015","article-title":"Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon","volume":"338","author":"Krishnamachari","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0142-9612(96)86742-1","article-title":"Degradation of poly(d,l-lactic acid) nanoparticles coated with albumin in model digestive fluids (USP XXII)","volume":"17","author":"Landry","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1472-6750-8-89","article-title":"Preparation of alginate coated chitosan microparticles for vaccine delivery","volume":"8","author":"Li","year":"2008","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1083\/jcb.123.3.595","article-title":"Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae","volume":"123","author":"Lisanti","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/erm.09.15","article-title":"Current advances in research and clinical applications of PLGA-based nanotechnology","volume":"9","author":"L\u00fc","year":"2009","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-0987(97)10007-0","article-title":"Binding and uptake of biodegradable poly-dl-lactide micro- and NPs in intestinal epithelia","volume":"6","author":"McClean","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0125","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1023\/A:1007696723125","article-title":"Design and in vivo evaluation of an oral delivery system for insulin","volume":"17","author":"Marsch\u00fctz","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W","article-title":"Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvid\u00f8re Study Group on Childhood Diabetes","volume":"15","author":"Mortensen","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0135","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jpeds.2009.05.025","article-title":"Glycemic control in youth with diabetes: the SEARCH for diabetes in youth study","volume":"155","author":"Petitti","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0169-409X(98)00040-4","article-title":"Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract","volume":"34","author":"Ponchel","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:PHAM.0000022411.47059.76","article-title":"The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers","volume":"21","author":"Qaddoumi","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2011.10.017","article-title":"Duodenum-specific drug delivery: in vivo assessment of a pharmaceutically developed enteric-coated capsule for a broad applicability in rat studies","volume":"442","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1091\/mbc.10.4.961","article-title":"Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles","volume":"10","author":"Rodal","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(92)90143-Z","article-title":"Caveolin, a protein component of caveolae membrane coats","volume":"68","author":"Rothberg","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jbm.b.30372","article-title":"Novel pH responsive polymethacrylic acid\u2013chitosan\u2013polyethylene glycol NPs for oral peptide delivery","volume":"76","author":"Sajeesh","year":"2006","journal-title":"J. Biomed. Mater. Res. B: Appl. Biomater."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0180","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan NPs are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1083\/jcb.124.3.307","article-title":"Protein kinase C activators inhibit receptor-mediated photocytosis by preventing internalization of caveolae","volume":"124","author":"Smart","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0190","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11095-008-9800-3","article-title":"Methods for the preparation and manufacture of polymeric NPs","volume":"26","author":"Vauthier","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0168-3659(02)00137-2","article-title":"Characterization of the initial burst release of a model peptide from poly(d,l-lactide-co-glycolide) microspheres","volume":"82","author":"Wang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0200","first-page":"231","article-title":"Enzyme-accelerated hydrolysis of polyglycolic acid","volume":"1","author":"Williams","year":"1977","journal-title":"J. Bioeng."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0205","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1023\/A:1018917412696","article-title":"Influence of anesthetic regimens on intestinal absorption in rats","volume":"10","author":"Yuasa","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.08.024_bib0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-3659(97)00106-5","article-title":"Influence of experimental parameters on the characteristics of poly(lactic acid) NPs prepared by a double emulsion method","volume":"50","author":"Zambaux","year":"1998","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312008198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312008198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T09:04:13Z","timestamp":1542791053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312008198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0378517312008198"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.08.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}